79
Growth Score in past quarter
pts
Heat Score 79 in past quarter
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
572458
Cellmover specializes in the development of therapeutics for cancer immunotherapy.
- Marit Inngjerdingen: Founder
- Kathrin Hnida: Product developer
About the Company
Cellmover develops products aimed at increasing the homing of therapeutic immune cells to tumors and also to increase the survival and persistence of immune cells within the tumor microenvironment.
The company was established in 2015 by immunologist Marit Inngjerdingen and serial entrepreneur Eirik Næss-Ulseth and is located within the Oslo
Cancer Cluster Incubator.